According to TG Therapeutics's latest financial reports the company has C$0.49 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | C$0.28 B | 31.5% |
2022-12-31 | C$0.21 B | -45.31% |
2021-12-31 | C$0.40 B | -48.04% |
2020-12-31 | C$0.77 B | 320.88% |
2019-12-31 | C$0.18 B | 95.42% |
2018-12-31 | C$93.85 M | -11.88% |
2017-12-31 | C$0.10 B | 76.58% |
2016-12-31 | C$60.31 M | -43.7% |
2015-12-31 | C$0.10 B | 17.19% |
2014-12-31 | C$91.41 M | 112.12% |
2013-12-31 | C$43.09 M | 163.37% |
2012-12-31 | C$16.36 M | 65.02% |
2011-12-31 | C$9.91 M | 1972.45% |
2010-12-31 | C$0.47 M | 2426.89% |
2009-12-31 | C$0.01 M | -85.31% |
2008-12-31 | C$0.12 M | -80.11% |
2007-12-31 | C$0.64 M | -81.62% |
2006-12-31 | C$3.52 M | -72.04% |
2005-12-31 | C$12.61 M | 93.76% |
2004-12-31 | C$6.5 M | -35.38% |
2003-12-31 | C$10.07 M | 270.59% |
2002-12-31 | C$2.71 M | 7.2% |
2001-12-31 | C$2.53 M | -36.46% |
2000-12-31 | C$3.99 M | -20.95% |
1999-12-31 | C$5.04 M | -43.39% |
1998-12-31 | C$8.91 M | -26.57% |
1997-12-31 | C$12.14 M | 285.51% |
1996-12-31 | C$3.15 M |